Skip to content

Clinical trials

Completed Carcinoma, Ovarian Epithelial trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Ovarian Epithelial Status: Completed Country / region: Australia Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20043
20052
20063
20091
20101
20111
20121
20131
20161
20191
20202
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gynecologic Oncology Group3
Eli Lilly and Company2
MEI Pharma, Inc.2
Prima BioMed Ltd2
AbbVie1
Bristol-Myers Squibb1
European Organisation for Research and Treatment of Cancer - EORTC1
Exelixis1
GlaxoSmithKline1
ImmunoGen, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Ovarian Epithelial21
Fallopian Tube Neoplasms14
Ovarian Neoplasms13
Carcinoma, Non-Small-Cell Lung2
Pancreatic Neoplasms2
Peritoneal Neoplasms2
Recurrence2
Triple Negative Breast Neoplasms2
Brenner Tumor1
Carcinoma, Renal Cell1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.